BRIEF published on 07/17/2026 at 18:05, 2 days 17 hours ago Update of ABIVAX's share capital and voting rights Share Capital Voting Rights Biotechnology Actions Abivax
BRIEF published on 07/06/2026 at 22:10, 13 days 13 hours ago Abivax Completes its $920 Million Public Offering Biotechnology Actions Funding Abivax Public Offering
BRIEF published on 07/06/2026 at 22:10, 13 days 13 hours ago Abivax Secures $920 Million in Public Offering Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares
PRESS RELEASE published on 07/06/2026 at 22:05, 13 days 13 hours ago Abivax Announces Closing of $920 Million Public Offering Abivax closes $920 million public offering, strengthening financial position. Proceeds to support operations until Q4 2029. Leerink Partners, Morgan Stanley, Piper Sandler, Guggenheim Securities involved in the offering Financial Position Abivax Morgan Stanley Public Offering Leerink Partners
BRIEF published on 07/02/2026 at 08:05, 18 days 3 hours ago Abivax successfully concludes an ADS offer Biotechnology Abivax Offer Ads Investments
BRIEF published on 07/02/2026 at 08:05, 18 days 3 hours ago Abivax's Offering Yields $920M Following Over-Allotment Exercise Biotechnology Abivax Obefazimod Capital Increase ADS Offering
PRESS RELEASE published on 07/02/2026 at 08:00, 18 days 3 hours ago Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) Abivax announces full exercise of underwriters' option to purchase additional ADSs, bringing gross proceeds of offering to $920M (€807M) Biotechnology Abivax Capital Increase Underwriters ADSs
BRIEF published on 07/01/2026 at 15:17, 18 days 20 hours ago Abivax resumes trading of its shares on Euronext Paris Euronext Paris Biotechnology Actions Abivax Suspension
BRIEF published on 07/01/2026 at 15:17, 18 days 20 hours ago Abivax relaunches trading of its shares on Euronext Paris Euronext Paris Ordinary Shares Abivax Inflammatory Diseases American Depositary Shares
BRIEF published on 07/01/2026 at 14:59, 18 days 20 hours ago Abivax Resumes Trading on Euronext Paris Euronext Paris Biotechnology Abivax Ulcerative Colitis American Depositary Shares
Published on 07/20/2026 at 08:00, 3 hours 23 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Q2 2026 Production Update
Published on 07/17/2026 at 15:00, 2 days 20 hours ago Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 2 days 21 hours ago Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 2 days 22 hours ago Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 3 days 10 hours ago RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/20/2026 at 11:00, 23 minutes ago Thailand cuts 3.8 million tonnes of CO₂ through low-carbon cement, accelerating beyond NDC targets and advancing a collaborative Net Zero model
Published on 07/20/2026 at 10:59, 23 minutes ago Aroundtown SA: Release of a capital market information
Published on 07/20/2026 at 10:50, 33 minutes ago PNE Group receives permits for wind energy projects totalling around 188 MW in Germany in the first half of 2026
Published on 07/20/2026 at 10:49, 34 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 07/20/2026 at 10:48, 34 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 07/17/2026 at 18:31, 2 days 16 hours ago Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 2 days 17 hours ago Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 2 days 17 hours ago Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 3 days 17 hours ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
